Activity of levofloxacin, ofloxacin, D-ofloxacin and ciprofloxacin against systemic and respiratory tract infections in laboratory animals.
Klesel
N
N
Hoechst AG Pharma Research, Frankfurt/Main, Germany.
Geweniger
K H
KH
Koletzki
P
P
Isert
D
D
Limbert
M
M
Markus
A
A
Riess
G
G
Schramm
H
H
Seibert
G
G
Iyer
P
P
D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control; D015169:Colony Count, Microbial; D024841:Fluoroquinolones; D007710:Klebsiella Infections / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D051379:Mice; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control
D000890:Anti-Infective Agents; D024841:Fluoroquinolones